Opko Health, Inc. (OPK)
OPK on American Stock Exchange
1.68USD
9 Feb 2010
1.68USD
9 Feb 2010
Price Change (% chg)
$-0.01 (-0.59%)
$-0.01 (-0.59%)
Prev Close
$1.68
$1.68
Open
--
--
Day's High
$1.69
$1.69
Day's Low
$1.65
$1.65
Volume
52,446
52,446
Avg. Vol
124,769
124,769
52-wk High
$2.91
$2.91
52-wk Low
$0.55
$0.55
OPK
About
Opko Health Inc. is a specialty healthcare company. The Company is focused on the discovery, development and commercialization of pharmaceuticals, drug delivery technologies, diagnostic systems, and instruments for the treatment, diagnosis and management of ophthalmic diseases and conditions. Its business consists of the... (more)
No analyst recommendations are available for OPK.
Overall
| Beta: | 1.38 |
| Market Cap (Mil.): | $426.29 |
| Shares Outstanding (Mil.): | 253.74 |
| Annual Dividend: | 0.00 |
| Yield (%): | NA |
Financials
| OPK | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 1.96 | 3.76 |
| EPS (TTM): | 34.86 | -- | -- |
| ROI: | -61.30 | 0.92 | 2.30 |
| ROE: | -84.64 | 1.27 | 2.82 |
UPDATE 1-U.S. FTC ok's Merck-Schering deal with conditions
* Merck sold interest in Merial animal health business (Adds background, quote)
Competitors
| Price | Change | |
|---|---|---|
| Genentech, Inc. (DNA.N) | -- | -- |
| Allergan, Inc. (AGN.N) | $58.75 | +0.58 |
| Alcon, Inc. (ACL.N) | $157.46 | +1.35 |
| Novartis AG (NOVN.VX) | CHF57.05 | +0.25 |
| Alnylam Pharmaceuticals, Inc. (ALNY.OQ) | $16.93 | +0.02 |
| Regeneron Pharmaceuticals, Inc. (REGN.OQ) | $26.26 | +0.49 |
| QLT Inc. (QLT.TO) | $4.81 | -0.02 |
| SurModics, Inc. (SRDX.OQ) | $19.66 | +0.11 |
| Carl Zeiss Meditec AG (AFXG.DE) | €12.35 | +0.14 |
| TOPCON CORPORATION (7732.T) | ¥448.00 | +6.00 |
Earnings vs 
Estimates
No consensus analysis data available.
© Copyright 2010 Thomson Reuters
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
